| Period | Period Low | Period High | Performance | |
|---|---|---|---|---|
| 1-Month | 554.500 +42.38% on 10/14/24 | | 817.000 -3.37% on 11/12/24 | +203.090 (+34.63%) since 10/11/24 |
| 3-Month | 554.500 +42.38% on 10/14/24 | | 1,009.000 -21.75% on 08/15/24 | -178.000 (-18.40%) since 08/12/24 |
| 52-Week | 554.500 +42.38% on 10/14/24 | | 1,770.000 -55.40% on 03/05/24 | -503.500 (-38.94%) since 11/10/23 |
December S&P 500 futures (ESZ23) are down -0.76%, and December Nasdaq 100 E-Mini futures (NQZ23) are down -0.92% this morning as the benchmark U.S. 10-year yield hit 5% for the first time since 2007 while...
/PRNewswire/ -- Indivior PLC (LSE: INDV), a global pharmaceutical company working to help change patients' lives by developing medicines to treat substance use...
/PRNewswire/ -- Indivior PLC (LSE: INDV), a leading addiction treatment company, announced that its subsidiary, Indivior Inc. (the "Company"), has reached an...
/PRNewswire/ -- Indivior PLC (LSE: INDV) today announced that it will participate in the following investor events: Jefferies Healthcare Conference – New York...
/PRNewswire/ -- Indivior PLC (LSE: INDV) today announced that its registration statement on Form 20-F required for the additional U.S. listing of its ordinary...
/PRNewswire/ -- Indivior PLC (LSE: INDV) today announced its financial results for the period ending March 31, 2023. The earnings release, investor...
/PRNewswire/ -- Indivior PLC (LSE: INDV) today announced that it will participate in the following investor event: Bank of America Global Healthcare Conference...
/PRNewswire/ -- Indivior PLC (LSE: INDV) ("Indivior" or the "Company") today announced that it has completed the acquisition of Opiant Pharmaceuticals, Inc....
/PRNewswire/ -- Indivior PLC (LSE: INDV) today announced 2022 Full Year Results. The earnings release, investor presentation, and webcast are available at...
/PRNewswire/ -- Indivior PLC (LON: INDV) today announced its financial results for the period ending September 30, 2022. The earnings release, investor...
| 3rd Resistance Point | 831.500 |
| 2nd Resistance Point | 817.000 |
| 1st Resistance Point | 808.500 |
| Last Price | 789.500 |
| 1st Support Level | 785.500 |
| 2nd Support Level | 771.000 |
| 3rd Support Level | 762.500 |
| 52-Week High | 1,770.000 |
| Fibonacci 61.8% | 1,305.679 |
| Fibonacci 50% | 1,162.250 |
| Fibonacci 38.2% | 1,018.821 |
| Last Price | 789.500 |
| 52-Week Low | 554.500 |